Home/Filings/4/0001209191-16-134938
4//SEC Filing

INTERLEUKIN GENETICS INC 4

Accession 0001209191-16-134938

CIK 0001037649operating

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:38 PM ET

Size

7.7 KB

Accession

0001209191-16-134938

Insider Transaction Report

Form 4
Period: 2016-07-29
Transactions
  • Purchase

    Common Stock Warrant (right to buy)

    2016-07-29+20,120,72420,120,724 total(indirect: See Note 1)
    Exercise: $0.10From: 2016-07-29Exp: 2023-07-29Common Stock (20,120,724 underlying)
  • Purchase

    Common Stock

    2016-07-29$0.10/sh+20,120,724$2,000,00055,418,811 total(indirect: See Note 1)
Footnotes (1)
  • [F1]The Reporting Person is a Director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"). NEA 14 is the sole member of Growth Equity Opportunities Fund III, LLC ("GEO") , the direct beneficial owner of the Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Shares held by GEO, except to the extent of his pecuniary interest therein.

Issuer

INTERLEUKIN GENETICS INC

CIK 0001037649

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001037649

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:38 PM ET
Size
7.7 KB